Description

Somatin (somatropin) lyophilisate for solution for injections 1.3 mg. (4 IU) №1 vial

Ingredients:

Each vial contains 1.3 mg (4 IU) of somatropin as the active ingredient. Other ingredients include mannitol, glycine, and sodium dihydrogen phosphate.

Dosage:

The recommended dosage of Somatin is individualized based on the patient’s weight, age, and condition. It is usually administered as a subcutaneous injection once daily. Consult a healthcare professional for the correct dosage.

Indications:

Somatin is indicated for the treatment of growth hormone deficiency in children and adults. It is also used in certain pediatric patients with short stature.

Contraindications:

Do not use Somatin if you have an active malignancy or a known hypersensitivity to somatropin. It is contraindicated in patients with closed epiphyses.

Directions:

Follow the instructions provided by your healthcare provider for the correct administration of Somatin. The lyophilisate should be reconstituted with the provided diluent before injection.

Scientific Evidence:

Somatin, containing somatropin as the active ingredient, has been extensively studied for its efficacy in treating growth hormone deficiency. Clinical trials have demonstrated significant improvements in height velocity and growth outcomes in pediatric patients receiving somatropin therapy.

Research published in the Journal of Clinical Endocrinology & Metabolism has shown that somatropin therapy can effectively increase lean body mass and reduce fat mass in adults with growth hormone deficiency, leading to improved body composition and metabolic parameters.

Additional Information:

• Storage: Store Somatin lyophilisate in the refrigerator at 2-8°C. Do not freeze.
• Adverse Effects: Common side effects may include injection site reactions, headache, and fluid retention. Consult your doctor if you experience any adverse reactions.